Filter
597
Filtered Results: 597
Text search:
infographic
Featured
Recommendations
81
New Publications
101
Language
Document type
No document type
161
Infographics
141
Studies & Reports
76
Guidelines
69
Manuals
45
Fact sheets
33
Resource Platforms
19
Strategic & Response Plan
19
Training Material
17
Situation Updates
9
Brochures
4
Videos
2
Dashboards/Maps
1
Online Courses
1
Countries / Regions
Global
27
Germany
23
Congo, Democratic Republic of
18
Syria
15
South Africa
11
Kenya
10
Latin America and the Carribbean
9
Sierra Leone
8
Western and Central Europe
8
Liberia
8
Nigeria
7
Guinea
7
Brazil
7
Ethiopia
7
South Sudan
7
Indonesia
7
Ukraine
6
Haiti
6
Yemen
6
Singapore
5
Senegal
5
India
5
Ghana
4
Burkina Faso
4
Philippines
4
Africa
4
Venezuela
4
Tanzania
4
South–East Asia Region
4
Eastern Europe and Central Asia
4
Uganda
4
Central African Republic
4
Myanmar / Burma
4
Rwanda
3
Italy
3
Guinea-Bissau
3
Nepal
2
Colombia
2
Lesotho
2
Turkey
2
Togo
2
Chile
2
Afghanistan
2
Malawi
2
Mozambique
2
Cambodia
2
West and Central Africa
2
United Kingdom
2
Côte d’Ivoire / Ivory Coast
2
Bangladesh
2
Moldova
2
Russia
2
Mali
2
Angola
2
Chad
2
Zambia
2
Iraq
2
Somalia
2
Pakistan
2
Benin
1
Gambia
1
Cameroon
1
Laos
1
Niger
1
Burundi
1
Peru
1
Malaysia
1
Zimbabwe
1
USA
1
Hungary
1
Jordan
1
Middle East and North Africa
1
Belarus
1
East and Southern Africa
1
Argentina
1
Sri Lanka
1
Namibia
1
Sudan
1
Romania
1
Palestine
1
Poland
1
Ecuador
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
174
Key Resources
36
Clinical Guidelines
33
Women & Child Health
23
Public Health
13
Capacity Building
11
Pharmacy & Technologies
2
Toolboxes
COVID-19
165
Mental Health
37
Ebola & Marburg
36
Planetary Health
27
Caregiver
25
Conflict
24
NTDs
23
Rapid Response
22
AMR
19
Zika
18
Disability
17
HIV
15
NCDs
15
Malaria
15
Global Health Education
13
Refugee
12
Natural Hazards
7
Specific Hazards
6
Cholera
4
TB
3
Health Financing Toolbox
3
Polio
2
Social Ethics
1
Pharmacy
1
Lancet Infectious Diseases Volume 22, Issue 11e327-e335.
In February, 2022, WHO published new guidelines with six recommendations to update the global public health strategy against schistosomiasis, including expansion of preventive chemotherapy eligibility from the predominant group of school-age...
December 2020 — May 2021
The Creditor Reporting System was analysed for official development assistance funding disbursements towards TB control in 11 conflict-affectedstates, 17 non-conflict-affected fragile states and 38 comparable non-fragile states. The amounts of funding, funding relative to burden, funding relative to...
Rabies is a disease of animals but too often the outcome is gauged in terms of human suffering and
death. Despite this, in areas of the world where rabies is endemic there is often a lack of communication between veterinary and medical professionals, to the extent that the disease continues to thri...
This document aims to provide global guidance on poliomyelitis (polio) surveillance in the context of the COVID-19 pandemic. It comes as a technical complement to Polio eradication programme continuity, Immunization in the context of COVID-19 pandemic frequently asked questions, and is aligned with ...
Malattie infettive come il COVID-19 possono implicare una interruzione delle attività negli ambienti in cui i bambini crescono e si sviluppano. Tali interruzioni, che coinvolgono famiglie, amicizie, routine quotidiane e la comunità nel suo senso più ampio, possono avere conseguenze negative sul b...
Working towards better COVID-19 outcomes in the WHO European Region.From the first COVID-19 cases in Europe reported on
24 January 2020, the pandemic reached 1 million cases
within 3 months, 10 million cases within 8 months, and
100 million cases in Europe alone within 2 years. Over
the course o...
Module 5
Monitoring and Evaluation
October 2018
Module 5: Monitoring and evaluation. This module is for people responsible for monitoring PrEP programmes at the national and site levels. It provides information on how to monitor PrEP for safety and effectiveness, suggesting core and additiona...
The conditionality of this recommendation is largely driven by the current higher unit cost of pyrethroid-PBO ITNs compared
to pyrethroid-only LLINs and therefore the uncertainty of their cost-effectiveness. Furthermore, as PBO is less wash-resistant
than pyrethroids, its bioavailability declines ...
Preferred product characteristics and clinical development considerations
